UPMC
VC Fund
Pittsburgh, United States
UPMC is a VC fund in Pittsburgh focused on Health Care and Medical. UPMC is one of the leading nonprofit health systems in the United States. A $500 billion integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, UPMC develops and delivers Life Changing Medicine by harnessing the power of technology, translating science into cures, and accelerating the pace of innovation worldwide.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 48%
Last updated:
For AI agents: llms.txt
Industries UPMC invests in
Stages UPMC invests in
Countries UPMC invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bonnie Anton
|
|||
Helen Sardo
|
|||
Jeanne Cunicelli
|
|||
John Houston
|
|||
Mark Ehalt
|
|||
| See all 13 contacts → | |||
Investment Focus
Industry
- Health Care 16 (55%)
- Medical 5 (17%)
- Biotechnology 5 (17%)
- Medical Device 5 (17%)
- Information Technology 4 (14%)
Stage
- Series A 7 (24%)
- Series B 5 (17%)
- Funding Round 5 (17%)
- Series C 3 (10%)
- Seed 1 (3%)
Country
- United States 18 (62%)
- Israel 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bonnie Anton
Informatics Nurse II eRecord Administration
|
Informatics Nurse II eRecord Administration | Total investments: 0 | Find email | |
|
Helen Sardo
Director
|
Director | Total investments: 0 | Find email | |
|
Jeanne Cunicelli
EVP UPMC, President UPMC Enterprises
|
EVP UPMC, President UPMC Enterprises | Total investments: 6 | Find email | |
|
John Houston
Vice President, Privacy and Information Security & Associate Counsel
|
Vice President, Privacy and Information Security & Associate Counsel | Total investments: 0 | Find email | |
|
Mark Ehalt
Sr. Director, Revenue Cycle Operations and Integrations
|
Sr. Director, Revenue Cycle Operations and Integrations | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Optain
|
Optain is a manufacturer of medical equipment and software. Optain is to make healthcare available to all people so that all can live healthy lives. Optain uses AI to create affordable clinical assistance solutions that make illness screening simple, anytime, and anywhere. | $26M / Series A / Sep 10, 2025 | |
Xealth
|
Xealth is a platform for digital health that enables health systems to easily organize, integrate, deploy and activate digital health tools from within the EHR workflow. Through the secure Xealth platform, clinicians can find and order the right digital tools and programs for patients direct from the EHR workflow, send these digital health ordersto the patient’s smartphone or desktop, and then monitor patient engagement and analyze the effects of more engaged patients. Xealth enables healthcare teams to order digital content and services as easily as they do medications today. The patients can then access these digital health prescriptions from the provider's portal so that they can actively manage their health. It spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC, and the Froedtert and Medical College of Wisconsin Health Network. | $25M / Series B / Oct 05, 2021 | |
CarepathRx
|
CarepathRx transforms hospital pharmacy from a cost center into an active revenue generator through a powerful combination of technology, market-leading pharmacy services and wrap-around services. | Corporate Round / Dec 01, 2020 | |
Abridge
|
Abridge provides an AI platform that transforms patient-clinician conversations into structured, billable clinical notes. This technology aims to reduce documentation burdens for clinicians and nurses. The system integrates into existing healthcare workflows and electronic health record systems. | $10M / Series A / Oct 06, 2020 | |
Prodigo Solutions
|
Prodigo Solutions, launched by healthcare supply chain professionals, is focused on driving real savings in the healthcare supply chain. Prodigo's suite of managed services and solutions are proven to drive contract compliance, automation, data quality and user adoption. Prodigo's suite of SaaS solutions includes ProdigoBuyer (web-basedrequisitioning with workflow), ProdigoMarketplace (content management and punchout audit) and ProdigoXchange (B2B transaction services like EDI and fax/email purchase orders). | Dec 19, 2019 | |
Werewolf Therapeutics
|
Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. We are leveraging our proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with thegoal of addressing the limitations of conventional proinflammatory immune therapies. Our INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Our most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors. | $56.2M / Series A / Nov 20, 2019 | |
RxAnte
|
RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members whileworking with their prescribers and caregivers to make regimens safer, simpler, and more affordable. | $5M / Apr 01, 2019 | |
|
RxAnte
|
RxAnte provides predictive analytics and targeted clinical programs that improve medication prescribing and adherence for health plans and their members. A significant component to these clinical programs is RxAnte’s Mosaic Pharmacy Service, which provides a superior pharmacy experience to a health plan’s most complex and vulnerable members whileworking with their prescribers and caregivers to make regimens safer, simpler, and more affordable. | Apr 01, 2019 | |
|
Xealth
|
Xealth is a platform for digital health that enables health systems to easily organize, integrate, deploy and activate digital health tools from within the EHR workflow. Through the secure Xealth platform, clinicians can find and order the right digital tools and programs for patients direct from the EHR workflow, send these digital health ordersto the patient’s smartphone or desktop, and then monitor patient engagement and analyze the effects of more engaged patients. Xealth enables healthcare teams to order digital content and services as easily as they do medications today. The patients can then access these digital health prescriptions from the provider's portal so that they can actively manage their health. It spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC, and the Froedtert and Medical College of Wisconsin Health Network. | $11M / Series A / Mar 27, 2019 | |
Health Catalyst
|
Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical. | $15M / Series F / Feb 08, 2019 | |
| See all 29 investments → | |||
Co-Investors
Norwest
3 deals together
Threshold
3 deals together
Veradigm
2 deals together
Birchmere Ventures
2 deals together
Draper Triangle
2 deals together
Gemini Israel Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does UPMC invest in?
UPMC invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact UPMC?
Public channels for UPMC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at UPMC?
The team at UPMC includes Bonnie Anton (Informatics Nurse II eRecord Administration), Helen Sardo (Director) and Jeanne Cunicelli (EVP UPMC, President UPMC Enterprises), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
